Search

Author/Creator Kadel, Edward

1. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). (4th November 2015)

Authors:
Powles, Thomas; Nickles, Dorothee; Van Allen, Eliezer; Chappey, Colombe; Zou, Wei; Kowanetz, Marcin; Kadel, Edward; Denker, Mitchell; Boyd, Zachary; Vogelzang, Nicholas; Kim, Joseph; Bellmunt, Joaquim; Loriot, Yohann; Drake, Charles G; O'Hear, Carol; Fasso, Marcella; Hegde, Priti; Mariathasan, Sa...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Issue 2 (December 2015)

Authors:
Powles, Thomas; Nickles, Dorothee; Van Allen, Eliezer; Chappey, Colombe; Zou, Wei; Kowanetz, Marcin; Kadel, Edward; Denker, Mitchell; Boyd, Zachary; Vogelzang, Nicholas; Kim, Joseph; Bellmunt, Joaquim; Loriot, Yohann; Drake, Charles; O'Hear, Carol; Fasso, Marcella; Hegde, Priti; Mariathasan, Sanjeev
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search